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Anatomy of the CNS opioid systems 
Henry Khachaturian, Michael E. Lewis, Martin K.-H. Sch~ifer and Stanley J. Watson 
The amzno acid sequences o f  the three endogenous opzoid peptzde precursors are 
known, and the anatomical distribution of  the opiozd peptzdes has been studied 
extensively This report summarizes these anatomical studzes and looks at the 
problems that result from the biochemical relatedness of  the precursors We also 
discuss the relatzonshzp of  opzozd systems to opzoid receptors, and the use of  
anatomical studies to derive new hypotheses of  opzozd function and provide 
dynamic measures of  opzoid neural actzvity, especially via specific mRNA 
quantitation_ 
The anatomical  distribution of endo- 
genous o p l o l d  peptides In the brain has 
been studied extensively, and has 
often preceded the complete structural 
characterization of the precursors 
from which these peptldes are denved  
In fact, immunocytochemscal studies 
in all three cases es tabhshed the 
cellular co-localization of oplold and 
related peptldes ei ther prior to or 
simultaneously with the biochemical 
and molecular  biological establish- 
ment  of their co-synthesis from a 
single precursor molecule The struc- 
tures of all three opiold precursors,  as 
determined from these approaches,  SIGNAL 
are shown in Fig 1. Due to necessary PEPTID[ 
hmltat lons in the space avadable for I 
describing three major ,  widely dlstrI- I 
buted neuronal  systems, we have 
focused on the most salient features of 
these systems and have necessanly 
hmzted the citations of a wide body of 
impor tant  h tera ture  on these peptides_ 
We have also restricted our anatomical 
descriptions (except where necessary) 
to observations made m the rat CNS 
and p~tmtary Suffice ~t to say that  
significant species differences have SIGNAL 
been noted in the dls tnbut ion of CNS PEPTID[ 
oplolds For further  detail, and a more 
complete list of references, the reader  
is referred to recent reviews 
nlng with the locahzatlon of 13-endor - 
phln, e,-endorphln and 13-11potropln (a 
POMC fragment containmg ~-endor- 
phln) lmmunoreactlvltles in the anter- 
ior lobe corttcotrophs and mtermedl-  
ate lobe melanotrophs n Electron- 
PROOPIOMELANOCORTIN I
P r o - o p i o m e l a n o c o r t i n  
Peptldes derived from pro-opio- 
melanocort in (POMC) include the 
opioid 13-endorphin, and the non- 
oplold hormones  A C T H  and ~-MSH 
(Fig 1) The POMC precursor is 
synthesized in both  the pituitary gland 
as well as the brain (Figs 2 and 3) 
The pituitary gland is a major  site of 
POMC biosynthesis Al though the 
existence of the pituitary peptides 
ACTH and 0~-MSH was already well 
established, the isolation and charac- 
terization of [3-endorphln as an opiate- 
active peptlde in 1976 by several 
laboratories 3 prompted  extensive 
immunoh~stochemical studies begin- 
microscopic lmmunocytochemlstry 
further  demonstra ted the existence of 
13-1ipotropzn and A C T H  In the same 
pituitary granules 5, thus raising the 
possibility of a biosynthetic link be- 
tween these peptldes Fur ther  bio- 
chemical studies 6 finally elucidated the 
protem structure of the POMC precur- 
sor which is processed to yield A C T H  
and 13-endorphln m the anterior  lobe, 
but o~-MSH and 13-endorphln m the 
intermediate lobe The full structure 
of the POMC precursor was later 
deduced from the sequence of c D N A  




C~-MSH JB-[ NOORPHIN 
( N-AC-ACTH 1- 13-NH2) 
i I I I 
t I t t = • 
"16 K" FRAGMENT 
PROENKEPHALIN I 
I 1 I I 
ACT H JiB - MSH 
I t I 
@-LPH 
I 2 3 
II I 
II • 
4 S 6 7 
m • I-I • 
• • u • 
U t__J U 
(-ARG-GLY- LEU) 1 (-ARG- PHI) 
PEPTIDE [ 
PRONEOENDORPHIN-DYNORPHIN I 
~ - ~  ,IB- NEO- 
[NDORPHIN J- -1  [ I 
I I i-e 1-13 
D D D 
DYN A DYN B 
SIGNAL PEPTIDE 11-17 II 1-Z9 
m =TYR-GLY-GLY-PHE-M[T ~ =TYR-GLY-GLY-PH[-L[U 
Fig .  1. Schematic representation of  the structure of  the three opzotd pepnde precursors Note that the 
opiate-active core sequence Tyr-Gly-Gly-Phe-Met ([Met]enkephahn) appears tn both pro- 
opzomelanocortm and proenkephahn, whde the opiate-active sequence Tyr-Gly-Gly-Phe-Leu 
([Leu]enkephahn) ts common to both proenkephahn and pro-neoendorphm-dynorphm 
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In the brain, there are two distract 
cell groups which contain POMC- 
denved pepUdes. The first is located in 
the areuate nucleus and with some 
cells scattered along the penarcuate 
medml-basal hypothalamus (Fig 3A) 
The second is found m the caudal 
nucleus tractus sohtarms (Fig 3B) 
Bloom et al. 7 and Watson et  a l  s 
demonstrated ACTH,  13-hpotropm, 
and 13-endorphm lmmunoreactlvities 
to be locahzed m neurons of the 
arcuate nucleus, and showed that 
these penkarya are &stmct from those 
containing the enkephalins Later, 13- 
endorphm, 13-hpotropm, and A C T H  
~mmunoreactwltles were all found to 
be co-localized in the same arcuate 
neurons 9, an observation which was 
confirmed by other investigators (Ref 
2) Similar co-locahzatlon studies were 
also camed  out using 0¢-MSH antl- 
sera ~°, raJsmg the posslbdlty of a brain 
POMC processing mechamsm slmdar 
to that shown to occur m the rater- 
me&ate lobe Watson and Akd r° 
further demonstrated a second, w~de- 
spread, extra-arcuate hypothalamic 
a-MSH-lt'nmunoreactive cell group 
which &d not exh~blt ~mmunoreactw- 
lty for any other POMC peptides 
Although the exact chemical nature of 
the a -MSH immunoreactive product 
of these neurons is still unknown, 
these neurones apparently project 
heavdy to the strmtum, hlppocampus, 
and cerebral cortex Later, at the 
annual meeting of the Society for 
Neurosclence m 1981, Schwartzberg 
and Nakane ~1 demonstrated another 
group of neurons which contained 13- 
endorphin, A C T H  and 16K (N-term- 
inal fragment of POMC) immunore- 
actwe material (Fig 3B) This group 
of small neurons resides within the 
commlssural nucleus and caudal nu- 
cleus tractus sohtarms, and exhibits 
projections that extend laterally and 
may innervate the lateral reticular 
nucleus 
The POMC neurons located m the 
arcuate nucleus have extensive proJec- 
tions throughout the brain (F~gs 2 and 
4), w~th the possible exceptmn of the 
stnatum, hippocampus, and cerebral 
cortex ~ Rostrally projecting fibers 
course through periventncular d~en- 
cephahc and telencephal~c areas, in- 
nervating many hypothalam~c and 
hmb~c structures, including preopt~c 
area, septum, and the bed nucleus of 
stria termmahs_ Lateral projections of 
the arcuate POMC neurons extend 
through the mechal-basal hypothala- 
mus ventrally and enter the amygda- 
Fig. 3. tA) ~hows [5-endorphm (B-END) ~mmunoreacttve neuron~ ~,~ the ar~uarr m~tleu.~ c,¢ ~u 
hypothalamus (V thtrd ventrtcle, cahbratzon bar = 100 Wn) In (B) 16K trnmunoreaf t~ e pertkar~ a a~d 
~een m the nucleus tractu3 ~ohtarlu3, par~ t ornmtssuralu o f  a one-day-old postnatal rat ,, ahhrallOH hdt 
50 ~tm) 
lold region of the temporal cortex 
Dorso-caudally projecting fibers 
course through the dorsal dien- 
cephalon to enter the mesencephalon 
and brainstem, innervating many areas 
associated with nociceptwe and other 
sensory integration These areas in- 
clude the penventricular thalamus 
(Ftg 4A) and penaqueductal  gray 
(Ftg 4B) Other caudal projections 
enter the brainstem ventrally to in- 
nervate numerous areas of the reti- 
cular formation, such as nucleus retl- 
culans glgantocellutans, retlculans 
laterahs, and raph~ magnus. Further 
bralnstem s~tes containing POMC 
~mmunoreactw~ty include the nucle~ 
parabrachlahs and amblguus, nucleus 
tractus sohtanus, and dorsal motor 
nucleus of vagus, areas that are re- 
volved m respiratory and cardiovas- 
cular regulation 
Proenkeph~in 
Unhke the POMC precursor which 
contains only one opioid peptlde (13- 
endorphm), several opiate-active pep- 
tides are derived from proenkephalin 
(Fig. 1) These are [Leu]enkephalin, 
[Met]enkephalin, [Met]enkephahn- 
Arg-Phe, [Met]enkephalin-Arg-Gly- 
Leu, and potentially several larger 
oploids (e.g BAM-22P, pepudes E 
and F) The proenkephahn precursor 
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~s synthesized in many neuronal sys- 
tems throughout the CNS, from the 
cerebral cortex down to the spinal cord 
(Figs 2 and 5A). 
[Leu]- and [Met]-enkephahn were 
first isolated from the brain by Hughes 
et al. I3 In 1975 and were shown at that 
time to be opiate active. The first 
lmmunocytochemical studies by Elde 
et al i4 and others 2 demonstrated a 
very similar distribution pattern for 
both [Leu]- and [Met]-enkephalin in 
brain neurons, which was apparently 
different from that seen for I~-endor- 
phm and related peptides 7,9 These 
preliminary studies were followed by 
many immunohlstochemlcal studies 
describing enkephalinergic neuronal 
systems, some forming local circuits, 
and others with long-tract proJec- 
tions 15-19 It is of course now known 
that [Met]- and [Leu]-enkephahn 
along with certain other C-terminally 
extended enkephalin pepudes are all 
denved from a single precursor, pro- 
enkephalin, the structure of which was 
deduced from molecular cloning and 
sequencing of cDNA from proen- 
kephahn mRNA (Ref. 1). 
To date, most immunocytochemlcal 
studies of CNS enkephahn-contammg 
neuronal systems are in good agree- 
ment regarding the widespread nature 
of these peptldes More recently, the 
use of relatively higher doses of the 
neurotoxm colchicine, which inhibits 
mlcrotubular axonal transport of nerve 
cell products, has enabled investi- 
gators to detect many more enke- 
phahn penkarya Thus, in addition to 
the many bramstem, mesencephalic 
and dlencephahc enkephalinerglc 
neuronal systems described previous- 
ly, we and other investigators have 
been able to detect extensive hippo- 
campal, amygdalold, cortical and 
other telencephalic neuronal orcults 
which exhibit enkephalin lmmuno- 
reactwlty ~s,~9 In these and numerous 
other studies of proenkephahn dlstn- 
butlon In CNS, ~t was consistently 
noted that enkephahn-containing 
neurons often existed in many brain 
areas alongside dynorphm-contaming 
neurons (Fig 5) Whether or not some 
CNS neuronal penkarya co-store these 
precursors is currently not known. 
Neurons containing proenk,~r)halin 
peptldes are found at virtually all 
levels of the neuraxls (Fig 2). Im- 
munoreactlve perikarya have been 
noted in most regions of the telence- 
phalon, including the cerebral cortex, 
olfactory tubercle, amygdala, hlppo- 
campus, stnatum, septum, bed nu- 
cleus of stna terminahs and preoptlc 
area. In diencephalon, penkarya are 
seen in most hypothalamic nuclei (Fig. 
5), and in the periventncular and 
lateral genlculate nucleus of thalamus. 
In the midbrain, enkephalinergic cells 
are localized in the colhculi, perlaque- 
ductal gray, and interpeduncular nu- 
cleus In the pons and medulla, peri- 
karya are seen in the parabrachlal, 
dorsal tegmental, vestibular and raph6 
nuclei, nuclei reticulans glgantocellu- 
laris and paragigantocellulans, nucleus 
tractus solitanus, lateral reticular nu- 
cleus, spinal tngeminal nucleus and 
spinal cord dorsal gray In addition to 
these areas which contain both enke- 
phahn perikarya and fibers, numerous 
other brain regions exhibit varying 
densities of fiber and termlnal-hke 
lmmunoreactivtty (Figs 2 and 6). From 
the foregoing, it should be apparent 
that the enkephahns have the potential 
to influence a wide variety of CNS 
functions 1,2 
Prodynorphin 
Prodynorphln (or pro-neoendor- 
phm-dynorphln), like proenkephahn, 
contains several opiate-active pep- 
tides, including dynorphln A, dynor- 
phm B (nmorphln), and a- or ~- 
neoendorphm (Fig. 1) This precursor 
is also synthesized throughout the 
Fig. 4. ~l-Endorphm (~-END) immunoreacttve fibers m parasaglttal sectzons through the 
penventncular nucleus of  thalamus (A) and the perlaqueductal gray of  mesencephalon (B) Compare 
w~th F~g 2 POMC prolecttons- Mlcrograph made using darkfleld opUcs AQ cerebral aqueduct, V 
lateral ventricle Cahbrat~on bar = 200 gm 
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CNS in a wide variety of neuronal 
systems (Figs 2 and 5B). 
In 1979, Goldstein et  a l  2o extracted 
from pituitary a 13 amino acid peptlde 
which contained the [Leu]enkephalin 
sequence at its N-terminus. The full 17 
amino aod  structure of this peptlde, 
now called dynorphin A, was later 
elucidated_ The second [Leu]enkepha- 
hn-contalnlng fragment of the precur- 
sor to be isolated was 0t-neoendorphin, 
which was extracted from the hypotha- 
lamus and fully sequenced A third 
peptlde, shown to be part of the C- 
terminus extension of dynorphin A,  
was also identified and termed dynor- 
phm B or rimorphm 1. Watson e t  al. 21 
demonstrated dynorphin A(1-13) 
lmmunoreactiwty m the postenor lobe 
of pituitary, and in hypothalamic 
supraoptlc and paraventricular nuclei, 
and further showed this pepttde to be 
co-localized with arginine-vasopressm 
m some magnocellular perikarya 22. 
Simdar observations were also made 
using anusera raised against dynorphin 
B and ~-neoendorptun, showing these 
peptides and dynorphm A to be co- 
localized within the same neurons in 
several regions of the brain 23,24 These 
results were m good agreement with 
the cloning and sequence analysis of 
prodynorphin cDNA demonstrating 
the co-synthesis of these peptides from 
a single precursor 1. 
Further lmmunocytochemlcal stud- 
les of dynorphin distribution in the 
CNS soon followed the imtml observa- 
tions, and, as was the case with the 
enkephahns, the application of colcht- 
cme enabled the detection of increas- 
ing numbers of smaller dynorphm 
penkarya throughout the brain and 
spinal cord 19,2~26. Our observations 
are summarized In Ftg 2. Immunore- 
active dynorphm perikarya are dmtn- 
buted in several cerebral cortical 
areas, stnatum, amygdala, h~ppo- 
campus, several hypothalamlc nuclei 
(including the supraoptic and paraven- 
tricular), midbram periaqueductal 
gray, and numerous brainstem areas, 
such as the parabrachial and spinal 
tngemmal nuclei, nucleus tractus soli- 
tanus, lateral reticular nucleus, and in 
the spinal cord dorsal horn. Addition- 
ally, fiber lmmunoreactlvtty is seen m 
many other areas of the brain as 
depicted in Figs 2 and 7 Mention 
should also be made of dynorphm 
Immunoreactlvlty in some as yet un- 
identified cells of the pttultary anterior 
lobe (Fig. 7B)_ However,  these cells 
are dtstinct from the cort~cotrophs 
which synthestze POMC When com- 
Fig. 5. Adlacent 4 ~m sect:ons through the hypothalamlc paraventrtcular nucleus (te]t ~s medial) 
tmmunostamed for [Leulenkephahn (ENK)(A ) and dynorphm B (D YN)(B ) Stars re&care a common 
vessel Note that the malortty o f  [Leu]enkephahn cells are concentrated In the parvocellular subdlvtston 
(dorsal and raedtal to the vessel), whde most dynorphm B cells ts m the magnocellular part (lateral to the 
vessel) Cahbrat~on bar = 100 ~xn 
panng the CNS distribution of the 
dynorphins and the enkephalins, it 
becomes obvtous that these two sys- 
tems are often anatoimcally conUg- 
uous (see Fig 5), and thus may 
participate (possibly via different re- 
ceptors) in several related CNS func- 
tions 
Problems of sequence homologies 
among the opioids 
Since the optate-actlve core se- 
quence of all opJoid peptides consists 
of either [Met]enkephalin or [Leu]- 
enkephahn (Fig. 1), there has been 
considerable difficulty and confusion 
in the lmmunocytochemical as well as 
btochemical separation of these pep- 
tides For example, the earher obser- 
vations of [Met]enkephahn-hke lm- 
munoreactivity in the anterior lobe 
corUcotrophs and Intermediate lobe 
cells were obviously due to significant 
antibody cross-reactivity and/or en- 
zymatic degradation that resulted m 
the detection of the N-terminal [Met]- 
enkephalin sequence of ~-endorphln 
in these cells In the case of [Leu]enke- 
phalin, however, we are faced with a 
considerably more difficult task. The 
amino acid sequence of this pentapep- 
tide is found in two opiold precursors 
T I N S -  March  1985 117 
proenkephahn, which contains one 
copy, and prodynorphm, which con- 
tams three copws as part of the N- 
terminal sequence of ot-neoendorphln, 
dynorphm A and dynorphin B As 
noted before, proenkephahn and pro- 
dynorphm neurons are often found in 
the same regaons of the brain (Fig. 5), 
comphcatmg the separation of the two 
precursor systems One of the most 
extensively investigated systems is the 
hypothalamlc magnocellular paraven- 
tricular and supraoptlc nuclei which 
synthesize the neuropeptldes oxytocm 
and vasopressm These cells project to 
the neural lobe of the p~tultary Imtml- 
ly, [Leu]enkephahn was extracted 
from the neuromtermedmte lobe of rat 
pitmtary and was shown to be local- 
lzed in the magnocellular nuclei 27_ 
Rossler et al_ 27 first suggested th~s 
peptide to be involved in the regula- 
tion of vasopressin and oxytocin. Mar- 
tin and Volgt 2s demonstrated the 
coexistence of [Met]enkephahn with 
oxytocin and [Leu]enkephalin with 
vasopressln m neurosecretory termin- 
als of the rat neurohypophysls. How- 
ever, the [Leu]enkephahn antiserum 
used was blockable by dynorphin A 
Subsequently, Watson et al.22.29, using 
highly punfied antisera, showed that 
prodynorphln is associated with vaso- 
pressm m magnocellular neurons and 
that [Leu]enkephahn and other pro- 
enkephalln peptldes are found in the 
parvocellular part of the paraventn- 
cular nucleus (Fig 5)_ However,  sigm- 
ficant species differences appear to 
exist m the processing of prodynorphin 
in the magnocellular nuclei For exam- 
ple, in the cat, substantial amounts of 
[Leu]enkephahn can be seen m the 
supraoptic nucleus 3° We have also 
made s~mllar observations m the 
rhesus monkey magnocellular system 
Recently, redirect evidence has also 
been presented for the processing of 
prodynorphln of stnatal orlgan into 
[Leu]enkephahn in the rat substantia 
nigra 31 However,  we have previously 
shown tn the rat that [Leu]enkephahn 
in substantm nigra ~s concentrated 
primarily m the pars compacta while 
dynorphm A is found mainly in the pars 
retlculata 29 In fact, through the use of 
antlsera directed against various pro- 
enkephahn and prodynorphln pep- 
tides, we have seen the pepUdes 
derived from each precursor co-local- 
ized within distract enkephahn-con- 
taming and dynorphin-contalnlng 
n e u r o n s  23'29'32 O f  course, these ob- 
servations do not necessarily exclude 
processing of some prodynorphm to 
[Leu]enkephalin in terminal fields. 
Nevertheless, because of the close 
anatomical proximity of the enkepha- 
hns and dynorphlns, biochemical data 
should also be regarded with caution 
since ~t is difficult to obtain tissue 
samples which contain one but not the 
other precursor_ 
Opioid peptide-receptor relationships 
Gwen the anatomical complexaty and 
relatedness of the multiple oploid 
systems, it is worth asking how the 
'messages' of these systems are differ- 
entiated at the receptor level_ Al- 
though there is abundant pharmaco- 
logacal and biochemical evidence for 
multiple subtypes of oplold recep- 
tors 33, the relationship of these recep- 
tors to the multiple op~o~d systems is 
not well understood However,  there 
is some rationale for making predic- 
tions, m vitro, the enkephalins bind 
preferentially to 6-0plold receptors, 
whale dynorphm-related peptldes bind 
preferentially to r-oplold receptors, 
and [3-endorphm brads to ~- and 6-, 
but not K-, oploid receptors 33_ Do these 
In-vitro associations predict anatomical 
relationships9 To began to explore this 
question, receptor autoradlographlc 
and lmmunocytochemlcal studies were 
carried out on adjacent sections of 
formaldehyde-perfused rat and rhesus 
B 
~ w ¢ ~ 
5 
f ~ 
W_ Illll ,. llIHI 
Fig. 6. (A) and (B) are parasaglttal sections showing the dLstrlbuaon o f  [Leu]enkephahn (ENK) 
lmmunoreacnvtty m the globus palhdus (A) and the dorsal horn of  the spinal cord (B) In (B) (cervical 
cord), note the dense tmmunoreacavlty zn lammae 1 and 2, and scattered trnmunoreacave pertkarya 
(arrows) zn lamina 5 Compare with Fig 2 proenkephahn proiecaons CI Internal capsule, CPU 
caudate-putamen, CU fascwulus cuneatus Cahbraaon bar = 200 pm 
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monkey brains 34-36 Apparent  Sx- and 
K-receptors are extenswely co-local- 
Ized m rat brain 37, and are distributed 
simdarly to enkephalin xmmunoreac- 
twlty m many (but not all) CNS areas, 
e.g some cerebral cortical areas, 
habenula, interpeduncular nuclear 
complex, parabrachial nuclei, nucleus 
tractus solitarius, spinal tngermnal 
nucleus, and dorsal horn of the spinal 
cord Such findings indicate that the 
ligand-receptor anatomical assocm- 
tions predicted by i n - v i t r o  studies (e g 
enkephalln-8) appear incorrect In- 
stead, since it ~s now known that some 
extended proenkephahn peptides have 
substantial i( and ~ properties 3s, wlule 
dynorphm A loses r select~vaty upon 
C-ternunal cleavage 3a,39, the apparent 
availability of multiple oploid recep- 
tors to each op~oid system may signify 
that differential processing of the 
op~oid precursor ~s a b~olog~cal strat- 
egy for yielding peptlde products 
which act at the different receptors 
Derivation of hypotheses of opioid 
function from anatomy 
Whenever neuroanatomlcal studtes 
are camed  out, there is always the 
hope that some aspect of neural 
function will be dlummated. The study 
of the anatomical distribution of 
oplold peptldes and receptors has not 
been disappointing m this regard; for 
example, oplold neurons and recep- 
tors are clearly part of the neural 
apparatus involved m noc~cepUon and 
analgesm Given the classical pharma- 
cology of opmtes, th~s assocmtion is 
not surpnsing_ However,  the study of 
oploid anatomy has given rise to less 
obvious possibdmes. For example, the 
study of oplo~d receptor d~stnbutlon 
has generated hypotheses concerning 
the role of opioids m multimodal 
sensory processing 4°,41 Based upon a 
sensory cortlcolimblc gradient of [3H]- 
naloxone binding sites m primate 
cerebral cortex, a possible role of 
opio~ds in selectwe attention was pro- 
posed 42 and supported by electro- 
physiological studies 43 Immunocyto- 
cheimcal studies of oplold peptlde 
systems have also been useful not only 
in providing an anatomical 'rationale' 
for the actions of opJolds on auto- 
nomic, neuroendocnne,  and behavior- 
al functions 1,2,12, but also for predict- 
lng previously unconsidered physio- 
logical roles of these peptides For 
example, our observation of enkepha- 
hn penkarya m the motor and mes- 
encephallc nuclei of the tngemmal 
may indicate a role for this oplold in 
the control of mastication 17 Llkewtse, 
the presence of enkephahn penkarya 
in the oculomotor and prepositus 
hypoglossal nuclei suggests a possible 
role in the regulation of eye move- 
ments 17 These examples show how 
anatomical studies can be useful m the 
generation of new hypotheses of 
op~old funcuon in the CNS 
Toward a dynamic opioid anatomy 
The anatomical localization of 
opiold peptldes has revealed exceed- 
mgly complex multiple systems. We 
are now faced with the task of unravel- 
ing the myriad of cell groups and 
projection systems m order to be able 
to derive further clues as to their 
functional significance Some of these 
projections have been determined 
with the use of combined Jmmuno- 
cytochemical and tract-tracing tech- 
niques Numerous other projections 
are yet to be elucidated. For example, 
m the case of POMC~ It has been 
assumed that all brain projections 
emanate from a single neuronal pop- 
ulatton residing m the hypothalamic 
arcuate nucleus However, the dis- 
covery of additional POMC neurons m 
FI B, 7. Dynorphm A (DYN) ~mmunoreacnmty ~ shown in two parasagatal level~ through the 
hlppocampal formation (A) and the pltuaary gland (B) In (A) the dentate gyru~ mossy ]ther 
prolecttons into areas CA2 and CA3 is DYN-pasttzve (cahbrauon bar = 400 ~rn) In ~B) the neural 
lobe contains D YN tmmanoreacttvlty Note also several lmmunoreacttve cells (arrows) m the antertor 
lobe (cahbrat:on bar = 200 I~n) Compare with Ftg 2 prodynorphm prolecnons AL antertor lobe 
CAI,2,3 cornu arnmoms ftelds 1, 2, and 3 IL mtermedzate lobe NL neural robe ~'G vtratum 
granulovum ~M stratum rnoleeulare SR stratum radzaturn 
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the nucleus  tractus solitarius,  and the 
fact that  this nucleus  (but  not  necessar-  
ily P O M C  neu rons )  p ro jec t s  to many  
POMC-r t ch  b ra ins t em and forebra in  
areas,  makes  xt impera t ive  to employ  
such combined  xmmunocytochemica l  
and tract- tracing techniques  to begin 
to sor t  ou t  the differential  p ro jec t ions  
of  these two P O M C - c o n t a l m n g  neur-  
onal  groups .  F r o m  tlus example ,  tt 
should be appa ren t  that  a considerably  
more  ddflcult  and extensive task 
awaits us in the case of  the p roenke -  
phal in  and p r o d y n o r p h i n  systems.  
Given  this complexi ty ,  tt would  also be  
useful to be able to s tudy the dynarmcs 
of  these sys tems in an anatomical  
context  I n - s t t u  c D N A - m R N A  hybrid-  
ization hls tochemis t ry  has  a l ready 
p roven  useful  for the localization of  
POMC-synthes tz ing  cells m pitui tary 
and brain  44, and rec6nt studies have 
shown  that this p rocedure  can be used 
to detect  the effects of  physiological  
t r ea tments  on P O M C  m R N A  levels 45, 
whtch appea r  to p r o w d e  an index of  
cellular blosyntheUc actlwty. Thus ,  
two  ma jo r  fu ture  direct ions of  opiotd 
anatomical  s tudws  will be to conduct  
detaded regional  immunocy tochemica l  
analyses of  oploid neurona l  projec-  
t ions in combina t ion  with tract-tracing 
me thods ,  as well as m - s i t u  hybridiza- 
tion of  oplold m R N A ,  to begin to 
p robe  the funct ional  significance of  the 
mult iple  systems descr ibed in this 
review 
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